SANUWAVE Health, Inc. SNWV Share-Based Payment - Unrecognized Cost of Nonvested Awards

Share-Based Payment - Unrecognized Cost of Nonvested Awards at other companies

UFP TechnologiesUFPT

$14.7M—

TTR

Turn Therapeutics Inc. Common StockTTRX

$1.2M—

Other financials

Income statement

See full

Revenue$9.6M+3.1%

Gross profit$7.4M+0.8%

Operating income-$1.1M-287%

Net income-$1.4M+76.5%

EPS (diluted)-$0.17+76.4%

Balance sheet

See full

Cash & equivalents$10.8M+26.8%

Total debt$21.7M+5,319%

Total equity$1.8M+109%

Total assets$37.1M+20.2%

Cash flow

See full

Operating cash flow$397.0K+126%

CapEx$23.0K-85.8%

Free cash flow$374.0K+122%

Valuation

See full

Market cap$85.99M+16.9%

Enterprise value$96.88M—

P/E5.2×—

P/S1.9×—

Profitability

See full

Gross margin76.7%+0.1pp

Operating margin7.3%-8.6pp

Net margin37.2%+21.6pp

FCF margin9%—

Returns & leverage

See full

Return on equity-173.8%—

Debt / equity11.8×—

Current ratio1.3×+0.9×

Where this comes from

Reported directly by SANUWAVE Health, Inc. in its filing.

Tagged under the XBRL concept us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized.

The official record: SANUWAVE Health, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about SANUWAVE Health, Inc.'s share-based payment - unrecognized cost of nonvested awards.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is SANUWAVE Health, Inc.'s share-based payment - unrecognized cost of nonvested awards?: SANUWAVE Health, Inc. (SNWV) reported share-based payment - unrecognized cost of nonvested awards of $10.8M in Q1 2026.
What does share-based payment - unrecognized cost of nonvested awards mean?: This represents the total compensation expense for equity-based awards that has been granted but not yet recognized in the income statement because the vesting conditions have not been met. It serves as a forward-looking indicator of future non-cash compensation expenses. Investors use this to forecast the impact of stock-based compensation on future earnings.